Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | September 20, 2023 01:31pm

Gainers

  • MSP Recovery (NASDAQ:LIFW) stock moved upwards by 118.1% to $0.2 during Wednesday's regular session. MSP Recovery's stock is trading at a volume of 436.7 million shares as of 13:30 EST. This is 3233.0% of its average full-day volume over the last 100 days. The company's market cap stands at $67.9 million.
  • Fresh Tracks Therapeutics (NASDAQ:FRTX) shares rose 54.22% to $0.9. The current volume of 9.9 million shares is 1515.7% of Fresh Tracks Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $5.3 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 49.01% to $4.62. Trading volume for this security as of 13:30 EST is 33.6 million, which is 5674.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.7 million.
  • Evaxion Biotech (NASDAQ:EVAX) shares rose 36.51% to $0.66. Trading volume for Evaxion Biotech's stock is 1.3 million as of 13:30 EST. This is 1998.7% of its average full-day volume over the last 100 days. The company's market cap stands at $18.1 million.
  • Histogen (NASDAQ:HSTO) stock increased by 31.87% to $0.52. Trading volume for this security as of 13:30 EST is 6.3 million, which is 8969.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock rose 28.95% to $0.68. As of 13:30 EST, this security is trading at a volume of 18.5 million shares, making up 7419.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 million.

Losers

  • Seelos Therapeutics (NASDAQ:SEEL) stock declined by 71.8% to $0.28 during Wednesday's regular session. Trading volume for this security as of 13:30 EST is 40.6 million, which is 4394.8% of its average full-day volume over the last 100 days. The company's market cap stands at $36.0 million.
  • ARS Pharmaceuticals (NASDAQ:SPRY) stock decreased by 56.25% to $2.89. The current volume of 15.6 million shares is 2778.3% of ARS Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $276.1 million.
  • Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares fell 16.67% to $0.0. As of 13:30 EST, Longeveron Inc. - Subscription Right's stock is trading at a volume of 2.8 million, which is 350.2% of its average full-day volume over the last 100 days.
  • Biolase (NASDAQ:BIOL) shares decreased by 14.4% to $1.79. The current volume of 684.2K shares is 249.5% of Biolase's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.8 million.
  • Butterfly Network (NYSE:BFLY) shares fell 14.39% to $1.19. The current volume of 4.5 million shares is 246.9% of Butterfly Network's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $245.8 million.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) shares declined by 12.47% to $0.77. Sonoma Pharmaceuticals's stock is trading at a volume of 63.1K shares as of 13:30 EST. This is 228.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BFLY BIOL BJDX EVAX FRTX HSTO LGVNR LIFW RNAZ SEEL SNOA SPRY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist